TreeWAS – Variant ID: rs76712070

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D25.9 Leiomyoma of uterus, unspecified	0.000	0.000	1.000
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.000	1.000
Z37.0 Single live birth	0.000	0.000	1.000
N40 Hyperplasia of prostate	1.000	0.000	0.000
N92 Excessive, frequent and irregular menstruation	0.000	0.000	1.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.000	1.000
N40-N51 Diseases of male genital organs	0.999	0.001	0.000
N80-N98 Noninflammatory disorders of female genital tract	0.000	0.001	0.999
N89 Other noninflammatory disorders of vagina	0.000	0.001	0.999
C61 Malignant neoplasm of prostate	0.999	0.001	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.002	0.998
N50 Other disorders of male genital organs	0.996	0.004	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.000	0.006	0.994
N47 Redundant prepuce, phimosis and paraphimosis	0.993	0.007	0.000
N50.8 Other specified disorders of male genital organs	0.989	0.011	0.000
N88 Other noninflammatory disorders of cervix uteri	0.000	0.022	0.978
N94.1 Dyspareunia	0.000	0.025	0.975
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.032	0.968
C60-C63 Malignant neoplasms of male genital organs	0.964	0.036	0.000
N94.6 Dysmenorrhoea, unspecified	0.000	0.037	0.963
N95 Menopausal and other perimenopausal disorders	0.000	0.046	0.954
Chapter XIV Diseases of the genitourinary system	0.014	0.048	0.939
N70-N77 Inflammatory diseases of female pelvic organs	0.007	0.061	0.932
N73.6 Female pelvic peritoneal adhesions	0.000	0.064	0.936
N73 Other female pelvic inflammatory diseases	0.003	0.065	0.932
Chapter II Neoplasms	0.931	0.069	0.000
D25 Leiomyoma of uterus	0.004	0.076	0.921
N50.1 Vascular disorders of male genital organs	0.924	0.076	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.923	0.077	0.000
D25.0 Submucous leiomyoma of uterus	0.000	0.084	0.915
D37-D48 Neoplasms of uncertain or unknown behaviour	0.915	0.085	0.000
N17-N19 Renal failure	0.002	0.090	0.908
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.091	0.909
N18 Chronic renal failure	0.000	0.103	0.897
N00-N08 Glomerular diseases	0.004	0.104	0.892
N18.3 Chronic kidney disease, stage 3	0.000	0.110	0.890
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.870	0.130	0.000
N43 Hydrocele and spermatocele	0.847	0.152	0.000
N92.5 Other specified irregular menstruation	0.000	0.162	0.837
N03 Chronic nephritic syndrome	0.002	0.171	0.827
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.828	0.172	0.000
N89.5 Stricture and atresia of vagina	0.000	0.172	0.828
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.811	0.189	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.810	0.190	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.789	0.211	0.000
D45 Polycythaemia vera	0.788	0.212	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.788	0.212	0.000
N95.1 Menopausal and female climacteric states	0.000	0.212	0.788
N18.2 Chronic kidney disease, stage 2	0.000	0.214	0.786
N03.9 Unspecified	0.000	0.219	0.781
N02 Recurrent and persistent haematuria	0.002	0.225	0.773
N88.2 Stricture and stenosis of cervix uteri	0.000	0.234	0.766
C92 Myeloid leukaemia	0.763	0.237	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.758	0.242	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.004	0.242	0.754
N94.3 Premenstrual tension syndrome	0.000	0.254	0.746
C93 Monocytic leukaemia	0.745	0.255	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.745	0.255	0.000
N18.4 Chronic kidney disease, stage 4	0.000	0.257	0.743
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.742	0.258	0.000
C51-C58 Malignant neoplasms of female genital organs	0.741	0.259	0.000
C15-C26 Malignant neoplasms of digestive organs	0.741	0.259	0.000
N43.3 Hydrocele, unspecified	0.739	0.261	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.738	0.262	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.738	0.262	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.735	0.265	0.000
N89.6 Tight hymenal ring	0.000	0.267	0.733
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.733	0.267	0.000
C85.1 B-cell lymphoma, unspecified	0.733	0.267	0.000
C62 Malignant neoplasm of testis	0.728	0.272	0.000
C60 Malignant neoplasm of penis	0.723	0.277	0.000
C18 Malignant neoplasm of colon	0.722	0.278	0.000
N92.2 Excessive menstruation at puberty	0.000	0.283	0.717
N51 Disorders of male genital organs in diseases classified elsewhere	0.716	0.283	0.000
N46 Male infertility	0.716	0.283	0.000
N44 Torsion of testis	0.716	0.283	0.000
N98 Complications associated with artificial fertilisation	0.000	0.283	0.716
N96 Habitual aborter	0.000	0.283	0.716
N89.7 Haematocolpos	0.000	0.284	0.716
N89.4 Leukoplakia of vagina	0.000	0.284	0.716
N89.3 Dysplasia of vagina, unspecified	0.000	0.284	0.716
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.000	0.284	0.716
N89.1 Moderate vaginal dysplasia	0.000	0.284	0.716
N89.0 Mild vaginal dysplasia	0.000	0.284	0.716
N95.3 States associated with artificial menopause	0.000	0.285	0.715
N50.9 Disorder of male genital organs, unspecified	0.714	0.285	0.000
N50.0 Atrophy of testis	0.714	0.285	0.000
N94.5 Secondary dysmenorrhoea	0.000	0.287	0.712
N94.4 Primary dysmenorrhoea	0.000	0.287	0.712
N94.2 Vaginismus	0.000	0.287	0.712
N94.0 Mittelschmerz	0.000	0.287	0.712
C90 Multiple myeloma and malignant plasma cell neoplasms	0.707	0.293	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.000	0.296	0.704
N45 Orchitis and epididymitis	0.702	0.298	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.000	0.299	0.701
N88.3 Incompetence of cervix uteri	0.000	0.299	0.701
N88.1 Old laceration of cervix uteri	0.000	0.299	0.701
N88.0 Leukoplakia of cervix uteri	0.000	0.299	0.701
N92.3 Ovulation bleeding	0.000	0.303	0.697
D46 Myelodysplastic syndromes	0.696	0.304	0.000
N91 Absent, scanty and rare menstruation	0.000	0.307	0.693
N71 Inflammatory disease of uterus, except cervix	0.004	0.308	0.687
C63 Malignant neoplasm of other and unspecified male genital organs	0.691	0.309	0.000
N76 Other inflammation of vagina and vulva	0.004	0.310	0.686
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.689	0.311	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.686	0.314	0.000
N95.9 Menopausal and perimenopausal disorder, unspecified	0.000	0.316	0.684
C53 Malignant neoplasm of cervix uteri	0.682	0.318	0.000
D47.1 Chronic myeloproliferative disease	0.681	0.319	0.000
D37.5 Rectum	0.677	0.323	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.674	0.326	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.005	0.327	0.668
C71 Malignant neoplasm of brain	0.673	0.327	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.672	0.328	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.328	0.672
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.672	0.328	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.003	0.329	0.668
N73.5 Female pelvic peritonitis, unspecified	0.003	0.329	0.668
N73.4 Female chronic pelvic peritonitis	0.003	0.329	0.668
N73.3 Female acute pelvic peritonitis	0.003	0.329	0.668
N73.2 Unspecified parametritis and pelvic cellulitis	0.003	0.329	0.668
N73.1 Chronic parametritis and pelvic cellulitis	0.003	0.329	0.668
N73.0 Acute parametritis and pelvic cellulitis	0.003	0.329	0.668
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.669	0.331	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.668	0.332	0.000
C50.9 Breast, unspecified	0.000	0.334	0.666
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.662	0.337	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.661	0.338	0.000
C95 Leukaemia of unspecified cell type	0.661	0.338	0.000
C94 Other leukaemias of specified cell type	0.661	0.338	0.000
C86 Other specified types of T/NK-cell lymphoma	0.661	0.338	0.000
N05 Unspecified nephritic syndrome	0.003	0.339	0.659
N95.2 Postmenopausal atrophic vaginitis	0.000	0.343	0.657
N70 Salpingitis and oophoritis	0.005	0.343	0.652
C82.1 Mixed small cleaved and large cell, follicular	0.657	0.343	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.656	0.344	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.656	0.344	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.655	0.345	0.000
D37.4 Colon	0.654	0.346	0.000
N02.8 Other	0.001	0.347	0.652
N19 Unspecified renal failure	0.001	0.349	0.651
C18.7 Sigmoid colon	0.644	0.356	0.000
N18.8 Other chronic renal failure	0.000	0.357	0.643
N18.1 Chronic kidney disease, stage 1	0.000	0.357	0.643
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.358	0.640
N06 Isolated proteinuria with specified morphological lesion	0.003	0.358	0.640
N01 Rapidly progressive nephritic syndrome	0.003	0.358	0.640
N00 Acute nephritic syndrome	0.003	0.358	0.640
C92.1 Chronic myeloid leukaemia	0.642	0.358	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.003	0.358	0.639
C82.0 Small cleaved cell, follicular	0.641	0.359	0.000
C18.2 Ascending colon	0.637	0.363	0.000
C16 Malignant neoplasm of stomach	0.633	0.367	0.000
D37.0 Lip, oral cavity and pharynx	0.633	0.367	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.632	0.367	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.002	0.372	0.626
N95.0 Postmenopausal bleeding	0.000	0.373	0.627
N92.4 Excessive bleeding in the premenopausal period	0.000	0.376	0.624
C88 Malignant immunoproliferative diseases	0.624	0.376	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.624	0.376	0.000
C85.0 Lymphosarcoma	0.624	0.376	0.000
N02.9 Unspecified	0.001	0.380	0.620
C53.9 Cervix uteri, unspecified	0.619	0.381	0.000
C18.0 Caecum	0.618	0.382	0.000
C93.1 Chronic monocytic leukaemia	0.618	0.382	0.000
N43.4 Spermatocele	0.608	0.392	0.000
N43.2 Other hydrocele	0.608	0.392	0.000
N43.1 Infected hydrocele	0.608	0.392	0.000
N43.0 Encysted hydrocele	0.608	0.392	0.000
C73 Malignant neoplasm of thyroid gland	0.606	0.394	0.000
C81 Hodgkin's disease	0.606	0.394	0.000
D39.1 Ovary	0.603	0.397	0.000
C50-C50 Malignant neoplasm of breast	0.399	0.399	0.203
N76.4 Abscess of vulva	0.002	0.401	0.597
D43.1 Brain, infratentorial	0.598	0.402	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.597	0.403	0.000
C34 Malignant neoplasm of bronchus and lung	0.596	0.404	0.000
N04 Nephrotic syndrome	0.003	0.404	0.593
C32 Malignant neoplasm of larynx	0.595	0.405	0.000
N03.8 Other	0.001	0.406	0.593
N03.7 Diffuse crescentic glomerulonephritis	0.001	0.406	0.593
N03.6 Dense deposit disease	0.001	0.406	0.593
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.001	0.406	0.593
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.406	0.593
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.406	0.593
N03.2 Diffuse membranous glomerulonephritis	0.001	0.406	0.593
N03.1 Focal and segmental glomerular lesions	0.001	0.406	0.593
N03.0 Minor glomerular abnormality	0.001	0.406	0.593
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.594	0.406	0.000
C82.6 Cutaneous follicle centre lymphoma	0.594	0.406	0.000
C82.5 Diffuse follicle centre lymphoma	0.594	0.406	0.000
C82.4 Follicular lymphoma grade IIIb	0.594	0.406	0.000
C82.3 Follicular lymphoma grade IIIa	0.594	0.406	0.000
C82.2 Large cell, follicular	0.594	0.406	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.592	0.408	0.000
C69 Malignant neoplasm of eye and adnexa	0.590	0.410	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.589	0.410	0.000
C84.4 Peripheral T-cell lymphoma	0.588	0.412	0.000
N82 Fistulae involving female genital tract	0.000	0.416	0.583
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.581	0.418	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.581	0.418	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.581	0.418	0.000
D47.4 Osteomyelofibrosis	0.581	0.418	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.581	0.418	0.000
D37.6 Liver, gallbladder and bile ducts	0.581	0.419	0.000
C52 Malignant neoplasm of vagina	0.580	0.420	0.000
N48 Other disorders of penis	0.580	0.420	0.000
C18.3 Hepatic flexure	0.580	0.420	0.000
N99-N99 Other disorders of the genitourinary system	0.010	0.421	0.570
C84.5 Other and unspecified T-cell lymphomas	0.574	0.426	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.573	0.427	0.000
C83.3 Large cell (diffuse)	0.573	0.427	0.000
N18.5 Chronic kidney disease, stage 5	0.000	0.428	0.572
D47.2 Monoclonal gammopathy	0.569	0.431	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.568	0.432	0.000
D37.9 Digestive organ, unspecified	0.566	0.434	0.000
D37.3 Appendix	0.566	0.434	0.000
D37.2 Small intestine	0.566	0.434	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.565	0.435	0.000
C70 Malignant neoplasm of meninges	0.565	0.435	0.000
C18.6 Descending colon	0.563	0.437	0.000
D48.0 Bone and articular cartilage	0.561	0.439	0.000
D43.0 Brain, supratentorial	0.559	0.441	0.000
C62.9 Testis, unspecified	0.559	0.441	0.000
C92.0 Acute myeloid leukaemia	0.559	0.441	0.000
C71.8 Overlapping lesion of brain	0.558	0.442	0.000
N76.8 Other specified inflammation of vagina and vulva	0.002	0.442	0.555
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.557	0.443	0.000
C71.3 Parietal lobe	0.557	0.443	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.001	0.444	0.554
N02.6 Dense deposit disease	0.001	0.444	0.554
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.001	0.444	0.554
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.001	0.444	0.554
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.001	0.444	0.554
N02.2 Diffuse membranous glomerulonephritis	0.001	0.444	0.554
N02.1 Focal and segmental glomerular lesions	0.001	0.444	0.554
N02.0 Minor glomerular abnormality	0.001	0.444	0.554
N60-N64 Disorders of breast	0.002	0.445	0.553
N18.0 End-stage renal disease	0.000	0.447	0.553
C83.0 Small cell (diffuse)	0.552	0.447	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.552	0.448	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.551	0.449	0.000
C53.0 Endocervix	0.551	0.449	0.000
C60.9 Penis, unspecified	0.550	0.449	0.000
C90.2 Plasmacytoma, extramedullary	0.550	0.450	0.000
C92.9 Myeloid leukaemia, unspecified	0.547	0.453	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.547	0.453	0.000
C92.7 Other myeloid leukaemia	0.547	0.453	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.547	0.453	0.000
C92.5 Acute myelomonocytic leukaemia	0.547	0.453	0.000
C92.4 Acute promyelocytic leukaemia	0.547	0.453	0.000
C92.3 Myeloid sarcoma	0.547	0.453	0.000
C92.2 Subacute myeloid leukaemia	0.547	0.453	0.000
C16.9 Stomach, unspecified	0.545	0.455	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.544	0.456	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.544	0.456	0.000
C31 Malignant neoplasm of accessory sinuses	0.544	0.456	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.544	0.456	0.000
C37 Malignant neoplasm of thymus	0.544	0.456	0.000
C33 Malignant neoplasm of trachea	0.544	0.456	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.003	0.457	0.540
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.003	0.457	0.540
D46.9 Myelodysplastic syndrome, unspecified	0.540	0.460	0.000
C91 Lymphoid leukaemia	0.535	0.464	0.000
N75 Diseases of Bartholin's gland	0.005	0.465	0.531
C93.9 Monocytic leukaemia, unspecified	0.534	0.466	0.000
C93.7 Other monocytic leukaemia	0.534	0.466	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.534	0.466	0.000
C93.2 Subacute monocytic leukaemia	0.534	0.466	0.000
C93.0 Acute monocytic leukaemia	0.534	0.466	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.534	0.466	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.534	0.466	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.534	0.466	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.534	0.466	0.000
C84.3 Lymphoepithelioid lymphoma	0.534	0.466	0.000
C84.2 T-zone lymphoma	0.534	0.466	0.000
C84.1 Sezary's diease	0.534	0.466	0.000
C84.0 Mycosis fungoides	0.534	0.466	0.000
C05 Malignant neoplasm of palate	0.533	0.467	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.532	0.468	0.000
C74 Malignant neoplasm of adrenal gland	0.532	0.468	0.000
C58 Malignant neoplasm of placenta	0.531	0.469	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.529	0.470	0.000
C83.7 Burkitt's tumour	0.529	0.470	0.000
C83.6 Undifferentiated (diffuse)	0.529	0.470	0.000
C83.5 Lymphoblastic (diffuse)	0.529	0.470	0.000
C83.4 Immunoblastic (diffuse)	0.529	0.470	0.000
C83.2 Mixed small and large cell (diffuse)	0.529	0.470	0.000
C83.1 Small cleaved cell (diffuse)	0.529	0.470	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.529	0.470	0.000
C46 Kaposi's sarcoma	0.529	0.470	0.000
C18.1 Appendix	0.527	0.473	0.000
D43.9 Central nervous system, unspecified	0.527	0.473	0.000
D43.7 Other parts of central nervous system	0.527	0.473	0.000
D43.4 Spinal cord	0.527	0.473	0.000
D43.3 Cranial nerves	0.527	0.473	0.000
D48.5 Skin	0.526	0.474	0.000
C34.0 Main bronchus	0.526	0.474	0.000
D39.9 Female genital organ, unspecified	0.526	0.474	0.000
D39.7 Other female genital organs	0.526	0.474	0.000
D39.2 Placenta	0.526	0.474	0.000
D39.0 Uterus	0.526	0.474	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.525	0.474	0.000
N05.9 Unspecified	0.002	0.475	0.524
N48.8 Other specified disorders of penis	0.525	0.475	0.000
Z37 Outcome of delivery	0.000	0.476	0.524
C62.1 Descended testis	0.522	0.478	0.000
C62.0 Undescended testis	0.522	0.478	0.000
C60.8 Overlapping lesion of penis	0.518	0.481	0.000
C60.2 Body of penis	0.518	0.481	0.000
C60.1 Glans penis	0.518	0.481	0.000
C60.0 Prepuce	0.518	0.481	0.000
C18.8 Overlapping lesion of colon	0.518	0.482	0.000
C23 Malignant neoplasm of gallbladder	0.518	0.482	0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere	0.514	0.486	0.000
N51.2 Balanitis in diseases classified elsewhere	0.514	0.486	0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere	0.514	0.486	0.000
N51.0 Disorders of prostate in diseases classified elsewhere	0.514	0.486	0.000
N98.9 Complication associated with artificial fertilisation, unspecified	0.000	0.486	0.514
N98.8 Other complications associated with artificial fertilisation	0.000	0.486	0.514
N98.3 Complications of attempted introduction of embryo in embryo transfer	0.000	0.486	0.514
N98.2 Complications of attempted introduction of fertilised ovum following in vitro fertilisation	0.000	0.486	0.514
N98.1 Hyperstimulation of ovaries	0.000	0.486	0.514
N98.0 Infection associated with artificial insemination	0.000	0.486	0.514
N71.1 Chronic inflammatory disease of uterus	0.003	0.486	0.511
C45 Mesothelioma	0.513	0.487	0.000
N86 Erosion and ectropion of cervix uteri	0.000	0.488	0.512
N73.9 Female pelvic inflammatory disease, unspecified	0.003	0.489	0.508
C90.0 Multiple myeloma	0.509	0.490	0.000
N70.1 Chronic salpingitis and oophoritis	0.002	0.492	0.506
C71.9 Brain, unspecified	0.507	0.493	0.000
C90.3 Solitary plasmacytoma	0.507	0.493	0.000
C90.1 Plasma cell leukaemia	0.507	0.493	0.000
D25.1 Intramural leiomyoma of uterus	0.002	0.496	0.502
C17 Malignant neoplasm of small intestine	0.504	0.496	0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.503	0.497	0.000
D43.2 Brain, unspecified	0.503	0.497	0.000
C50 Malignant neoplasm of breast	0.017	0.498	0.485
D46.7 Other myelodysplastic syndromes	0.499	0.501	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.499	0.501	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.499	0.501	0.000
D46.4 Refractory anaemia, unspecified	0.499	0.501	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.499	0.501	0.000
D46.2 Refractory anaemia with excess of blasts	0.499	0.501	0.000
D46.1 Refractory anaemia with sideroblasts	0.499	0.501	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.499	0.501	0.000
C16.2 Body of stomach	0.499	0.501	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.003	0.503	0.494
N91.5 Oligomenorrhoea, unspecified	0.000	0.503	0.497
N91.4 Secondary oligomenorrhoea	0.000	0.503	0.497
N91.3 Primary oligomenorrhoea	0.000	0.503	0.497
N91.1 Secondary amenorrhoea	0.000	0.503	0.497
N91.0 Primary amenorrhoea	0.000	0.503	0.497
C18.5 Splenic flexure	0.496	0.504	0.000
N71.0 Acute inflammatory disease of uterus	0.003	0.504	0.493
C63.9 Male genital organ, unspecified	0.495	0.504	0.000
C63.8 Overlapping lesion of male genital organs	0.495	0.504	0.000
C63.7 Other specified male genital organs	0.495	0.504	0.000
C63.2 Scrotum	0.495	0.504	0.000
C63.1 Spermatic cord	0.495	0.504	0.000
C63.0 Epididymis	0.495	0.504	0.000
N64 Other disorders of breast	0.001	0.504	0.494
N76.5 Ulceration of vagina	0.003	0.505	0.492
N76.3 Subacute and chronic vulvitis	0.003	0.505	0.492
N76.1 Subacute and chronic vaginitis	0.003	0.505	0.492
N70.9 Salpingitis and oophoritis, unspecified	0.003	0.506	0.492
N49.9 Inflammatory disorder of unspecified male genital organ	0.494	0.506	0.000
N49.8 Inflammatory disorders of other specified male genital organs	0.494	0.506	0.000
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens	0.494	0.506	0.000
N49.0 Inflammatory disorders of seminal vesicle	0.494	0.506	0.000
D44.3 Pituitary gland	0.492	0.507	0.000
C34.3 Lower lobe, bronchus or lung	0.490	0.510	0.000
C10 Malignant neoplasm of oropharynx	0.489	0.511	0.000
C53.8 Overlapping lesion of cervix uteri	0.489	0.511	0.000
C53.1 Exocervix	0.489	0.511	0.000
C71.1 Frontal lobe	0.489	0.511	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.489	0.511	0.000
C18.4 Transverse colon	0.486	0.514	0.000
D37.7 Other digestive organs	0.484	0.516	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.483	0.517	0.000
D48.4 Peritoneum	0.483	0.517	0.000
D48.3 Retroperitoneum	0.483	0.517	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.483	0.517	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.004	0.517	0.479
N74.4 Female chlamydial pelvic inflammatory disease	0.004	0.517	0.479
N74.3 Female gonococcal pelvic inflammatory disease	0.004	0.517	0.479
N74.2 Female syphilitic pelvic inflammatory disease	0.004	0.517	0.479
N74.1 Female tuberculous pelvic inflammatory disease	0.004	0.517	0.479
N74.0 Tuberculous infection of cervix uteri	0.004	0.517	0.479
C71.7 Brain stem	0.483	0.517	0.000
C71.6 Cerebellum	0.483	0.517	0.000
C71.5 Cerebral ventricle	0.483	0.517	0.000
C71.4 Occipital lobe	0.483	0.517	0.000
C71.0 Cerebrum, except lobes and ventricles	0.483	0.517	0.000
D38.1 Trachea, bronchus and lung	0.482	0.518	0.000
D48.7 Other specified sites	0.482	0.518	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.481	0.518	0.000
C13 Malignant neoplasm of hypopharynx	0.481	0.518	0.000
C11 Malignant neoplasm of nasopharynx	0.481	0.518	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.481	0.518	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.481	0.518	0.000
C04 Malignant neoplasm of floor of mouth	0.481	0.518	0.000
C03 Malignant neoplasm of gum	0.481	0.518	0.000
C00 Malignant neoplasm of lip	0.481	0.518	0.000
C12 Malignant neoplasm of pyriform sinus	0.481	0.518	0.000
C16.5 Lesser curvature of stomach, unspecified	0.481	0.519	0.000
C57.0 Fallopian tube	0.481	0.519	0.000
D44.9 Endocrine gland, unspecified	0.479	0.520	0.000
D44.8 Pluriglandular involvement	0.479	0.520	0.000
D44.7 Aortic body and other paraganglia	0.479	0.520	0.000
D44.6 Carotid body	0.479	0.520	0.000
D44.5 Pineal gland	0.479	0.520	0.000
D44.4 Craniopharyngeal duct	0.479	0.520	0.000
D44.2 Parathyroid gland	0.479	0.520	0.000
D44.1 Adrenal gland	0.479	0.520	0.000
D44.0 Thyroid gland	0.479	0.520	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.479	0.521	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.479	0.521	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.479	0.521	0.000
N20-N23 Urolithiasis	0.004	0.521	0.475
C48.0 Retroperitoneum	0.478	0.522	0.000
D38.6 Respiratory organ, unspecified	0.475	0.525	0.000
D38.5 Other respiratory organs	0.475	0.525	0.000
D38.4 Thymus	0.475	0.525	0.000
D38.3 Mediastinum	0.475	0.525	0.000
D38.2 Pleura	0.475	0.525	0.000
D38.0 Larynx	0.475	0.525	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.525	0.473
C19 Malignant neoplasm of rectosigmoid junction	0.475	0.525	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.474	0.526	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.474	0.526	0.000
C86.4 Blastic NK-cell lymphoma	0.474	0.526	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.474	0.526	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.474	0.526	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.474	0.526	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.474	0.526	0.000
C94.7 Other specified leukaemias	0.474	0.526	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.474	0.526	0.000
C94.5 Acute myelofibrosis	0.474	0.526	0.000
C94.4 Acute panmyelosis	0.474	0.526	0.000
C94.3 Mast cell leukaemia	0.474	0.526	0.000
C94.2 Acute megakaryoblastic leukaemia	0.474	0.526	0.000
C94.1 Chronic erythraemia	0.474	0.526	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.474	0.526	0.000
C95.9 Leukaemia, unspecified	0.474	0.526	0.000
C95.7 Other leukaemia of unspecified cell type	0.474	0.526	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.474	0.526	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.474	0.526	0.000
C95.0 Acute leukaemia of unspecified cell type	0.474	0.526	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.474	0.526	0.000
C96.8 Histiocytic sarcoma	0.474	0.526	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.474	0.526	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.474	0.526	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.474	0.526	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.474	0.526	0.000
C96.3 True histiocytic lymphoma	0.474	0.526	0.000
C96.2 Malignant mast cell tumour	0.474	0.526	0.000
C96.1 Malignant histiocytosis	0.474	0.526	0.000
C96.0 Letterer-Siwe disease	0.474	0.526	0.000
N05.8 Other	0.002	0.526	0.472
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.526	0.472
N05.6 Dense deposit disease	0.002	0.526	0.472
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.526	0.472
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.526	0.472
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.526	0.472
N05.2 Diffuse membranous glomerulonephritis	0.002	0.526	0.472
N05.0 Minor glomerular abnormality	0.002	0.526	0.472
N91.2 Amenorrhoea, unspecified	0.000	0.526	0.474
C18.9 Colon, unspecified	0.473	0.527	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.472	0.528	0.000
D40.9 Male genital organ, unspecified	0.470	0.530	0.000
D40.7 Other male genital organs	0.470	0.530	0.000
D40.1 Testis	0.470	0.530	0.000
D40.0 Prostate	0.470	0.530	0.000
D42.9 Meninges, unspecified	0.470	0.530	0.000
D42.1 Spinal meninges	0.470	0.530	0.000
D42.0 Cerebral meninges	0.470	0.530	0.000
C21 Malignant neoplasm of anus and anal canal	0.467	0.533	0.000
N49.2 Inflammatory disorders of scrotum	0.466	0.534	0.000
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.536	0.464
N76.6 Ulceration of vulva	0.003	0.536	0.461
C51 Malignant neoplasm of vulva	0.463	0.537	0.000
N64.5 Other signs and symptoms in breast	0.000	0.537	0.462
N00.9 Unspecified	0.002	0.539	0.459
N00.8 Other	0.002	0.539	0.459
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.539	0.459
N00.6 Dense deposit disease	0.002	0.539	0.459
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.539	0.459
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.539	0.459
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.539	0.459
N00.2 Diffuse membranous glomerulonephritis	0.002	0.539	0.459
N00.1 Focal and segmental glomerular lesions	0.002	0.539	0.459
N00.0 Minor glomerular abnormality	0.002	0.539	0.459
N01.9 Unspecified	0.002	0.539	0.459
N01.8 Other	0.002	0.539	0.459
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.539	0.459
N01.6 Dense deposit disease	0.002	0.539	0.459
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.539	0.459
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.539	0.459
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.539	0.459

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations